COURSE NUMBER: MBA292B.11

This course is dual-listed with Evening-weekend MBA

COURSE TITLE: Nonprofit Boards and Governance

UNITS OF CREDIT: 1

INSTRUCTOR: Paul Jansen

E-MAIL ADDRESSpaul55jansen@gmail.com

Please note the unorthodox nature of this course, which meets all day on 2 Sundays. To earn a passing grade, you must attend BOTH class sessions in their entirety. Consult the Spring 2019 electives spreadsheet for meeting dates.

PREREQUISITE(S): None

CLASS FORMAT: Lecture, discussion, case studies, panel discussions with experienced directors and CEOs from local nonprofits

REQUIRED READINGS: Primarily published articles, BoardSource governance materials and The Dynamic Nonprofit Board:  Lessons from High Performing Nonprofits

BASIS FOR FINAL GRADE: 40% participation, 60% for 2 case write ups

CAREER FIELD:    This course is for business oriented students who anticipate they might serve on a nonprofit board(s) over the course of their career or for students interested in managerial roles at nonprofit organizations who will need to interact with the nonprofit’s board of directors regularly.  

ABSTRACT OF COURSE'S CONTENT AND OBJECTIVES:  This one-unit course provides students with a working knowledge of the role played by boards of directors in the nonprofit sector and prepares them to be active and informed members of nonprofit board.  My mindset is that of exposing you to all the things I wish that I had known before I started my own nonprofit board career.  Specifically, the course will explore the following aspects of boards:

Students will have the opportunity to meet members of the Bay Area nonprofit sector, including current board members, chief executives, and fund raisers to discuss their roles and learn firsthand the challenges facing these different leaders in an increasingly competitive nonprofit marketplace.  

BIOGRAPHICAL SKETCH: Paul Jansen is an adjunct professor at Haas.  Paul spent 25 years as a consultant at McKinsey & Company before retiring in 2009.  In 2001, he co-founded the Firm’s Nonprofit Practice, which later evolved into the Social Sector Practice.  At various times, he has held roles as leader of the global nonprofit practice, knowledge leader and director of the global philanthropy practice.  In these roles, his client work focused on strategy, organization development, and operations issues, where he gained particular experience in global health, higher education, nonprofit governance and public-private partnerships.
Paul has authored a number of articles including “For Nonprofits, Time is Money” which stimulated sector-wide discussion on the strategic benefit of increasing endowment payout rates.  With former Senator Bill Bradley wrote an article for the Harvard Business Review, entitled “The Non-Profit Sector’s $100 Billion Opportunity”, which again challenged sector beliefs about the potential for improved performance.  Paul has also co-authored a report entitled “The Dynamic Board: Lessons from High-Performing Nonprofits”, which examines board governance issues unique to the nonprofit community.   Paul co-authored a report released in 2009 on philanthropic prizes “And the Winner is…Capturing the Promise of Philanthropic Prizes

Paul received a chemical engineering degree from the University of California at Berkeley and earned his MBA at the Harvard Business School.  His governance experience includes serving as chair of the Board of CARE USA, which is committed to reducing poverty worldwide and as a director of the SCE Fund, a philanthropic foundation, Care International Supervisory Board, and Care Enterprises, a for profit social impact investor.   He also serves on advisory boards for Inside Track, an organization that seeks to improve college retention, Imagine H20, which seeks to impact water issues, Strive for College, which strives to increase college attendance by high risk students.  Paul also spent 15 years serving on the board of the San Francisco Zoological Society, including 4 years as chairman on the board.  Paul recently joined the board of directors of Zymergen, a pre-IPO molecular engineering products and services company.